medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2009, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2009; 56 (2)

Impact of the use of Heberfastline® pregnancy diagnosis in consultations of menstrual regulation (MR) in the Province of Sancti Spiritus, Cuba, from July 2006 to January 2007

Ibargollín UR, Leal GV, Alfonso RCJ, Torres GE, Escobar CE, Abraham ME

Language: Spanish
References: 25
Page: 125-131
PDF size: 107.72 Kb.


ABSTRACT

It was carried out a descriptive and interventive study to evaluate the impact of the use Pregnancy Diagnostician HeberFastLine®; a product elaborated in the Center of Genetic Engineering and Biotechnology of Sancti-Spiritus, registered with a high specificity (100%) and sensibility (99.7%); in consultations of Menstrual Regulation (RM) previous to performing the procedure in period from July 2006 to January 2007. The sample was made up by 4,539 patients who had the diagnostician. The diagnosis was carried out starting from gathering of the tomorrow’s first urine and in the positive cases we proceeded to the interruption depending of the Age of Pregnancy. To validate the gathering of data, the beneficiaries patients were registered and the execution of the established flow chart. With the diagnostician’s use, we found 41.6% of ribbons with negative result, where the risk was eliminated, the assisted teenagers represented 28.6% and out of them 12.06% avoided the procedure, 11.1% of the patients had the antecedent of Pelvic Inflammatory Illness, out of them 47.0% had ribbons with negative results, 72.6% had the antecedent of previous interruptions, from which 40.6% of negative ribbons, only 50.5% of the studied patients underwent RM. Out of a total of 53 diagnoses, 28.3% was ectopic pregnancy, out of them 84.6% non complicated and 28.3% ovary cysts as cause of secondary amenorrhea, with a percentage of variability of -23.6% of induced abortions in the province during the second semester of 2006 with regard to the first one.


REFERENCES

  1. World Health Organization (WHO). Safe abortion: Technical and policy guidance for health systems. Geneva: WHO; 2003.

  2. Barreto T et al. Investigating induced abortion in developing countries: Methods and problems. Studies in Family Planning 1992; 23 (3): 159-170.

  3. AGI. Aborto clandestino: Una realidad latinoamericana. Nueva York: AGI; 1994.

  4. Singh S, Wulf D, Jones H. Health professionals perceptions about induced abortion in South Central and Southeast Asia. Internat Fam Plann Perspect 1997; 23 (2): 59-67.

  5. Goldberg AB, Gillian Dean, Mi-Suk Kang, Youssof S, Darney P. Manual versus electric vacuum aspiration for early first-trimester abortion: A controlled study of complication rates. Am Coll Obstetr Gynecol 2004; 103 (1).

  6. Registro de diagnosticadores. Centro para el Control Estatal de la Calidad de los Medicamentos. Ministerio de Salud Pública. 1996; No. D9708-11.

  7. Daylily S, Sherry L, Claman P, Henry F. Serum human chorionic gonadotrophin levels in early pregnancy. Clin Chem Act 1989; 181: 282-292.

  8. Miller E, Fortney J. Early vacuum aspiration. Minimizing procedures to non pregnant women. Fam Plann Perspect 1996; 8: 33-38.

  9. Åhman E, Iqbal Shah. Unsafe abortion: Worldwide estimates for 2000. Reprod Health Matt 2002; 10 (19): 13–17.

  10. Ipas. 2003. Medical abortion: Implications for Africa. Chapel Hill, NC, Ipas. (en línea) Accedido Junio 2006. Disponible en: http://www.ipas.org/english/womens_health/abortion_care/default.asp

  11. Åhman, Elisabeth and Iqbal Shah. Unsafe abortion: Worldwide estimates for 2000. Reprod Health Matt 2002; 10 (19): 13–17.

  12. Braunstein G, Rasor J, Adler D, Danzer H, Wade M. Serum human chorionic gonadotropin levels throughout normal pregnancy. Am J Obstet Gynecol 1986; 126: 678-681.

  13. Hussa R. Human chorionic gonadotropin, a clinical marker: Review of its biosynthesis. Ligand Rev 1991; 3 (suppl 2): 6-43.

  14. Nurit R, Imbar M, Hexter C. Monoclonal antibody specific to the beta subunit of human chorionic gonadotropin (hCG) and capable of agglutinating hCG-coated red blood cells. Hybridoma 1994; 3: 49-55.

  15. Chian RC, Buckett WM, Tulandi T, Tan SJ. Prospective randomized study of human chorionic gonadotropin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Rep 2000; 15 (1).

  16. Sugantha SE, Webster S, Sundar E, Lenton EA. Predictive value of plasma human chorionic gonatrophin in following assisted conception treatment. Hum Rep 2000; 15 (1).

  17. Austin J. Diagnóstico de la patología endometrial, mediante legrado por aspiración. Actas Ginecol 1982; 39: 3.

  18. Trinh Huu Vach, Amie Bishop, Vuong Thi Hoa, Luong Xuan Hien, Tran Dinh Chien, Tuong I Nguyen. The potential impact of introducing pregnancy testing into menstrual Regulation Services in Vietnam. International Family Planning Perspectives 1998; 24 (4): 165-169.

  19. Torres E, Muñoz M et al. Validación clínica del inmunoensayo rápido BioLine-hCG para el diagnóstico precoz del embarazo BioLine-hCG. Rev Cub Med 1998; 37 (3): 131-135.

  20. Figueroa R, Casanova M, Cortiza G, Águila I, Ocaña MA. Ginecología Infanto-Juvenil. Desarrollo alcanzado en la provincia de Cienfuegos. Rev Cub Obstet Ginecol 2001; 27 (3): 191-198.

  21. Gómez R. La regulación menstrual. Complicaciones y efectividad. Policlínico docente «Dr. Manuel Díaz Legrá». Diciembre 1995-Diciembre 1996. Correo Científico Médico de Holguín 2000; 4 (2).

  22. Joyce. The social and economic correlates of pregnancy resolution among adolescents in New York by race and ethnicity: A multivariate analysis. Am J Public Health 2003; 6: 626-631.

  23. Casanova C. Epidemiología del embarazo ectópico en un hospital ginecoobstétrico. Rev Cub Enferm 2003; 19 (3).

  24. Bulusu S. Secondary amenorrhoea. J R Soc Med 2006; 89: 220P-221P.

  25. Neinstein LS. Menstrual dysfunction in pathophysiologic states. Clin Rev West J Med 1985; 143: 476-484.




2020     |     www.medigraphic.com